See more : Hitron Systems Inc. (019490.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Hogy Medical Co.,Ltd. (HGYMF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hogy Medical Co.,Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- ShiftPixy, Inc. (PIXY) Income Statement Analysis – Financial Results
- Nordic LEVEL Group AB (publ.) (LEVEL.ST) Income Statement Analysis – Financial Results
- International Biotechnology Trust plc (IBT.L) Income Statement Analysis – Financial Results
- Jiangsu Expressway Company Limited (JEXYY) Income Statement Analysis – Financial Results
- Chongyi Zhangyuan Tungsten Co., Ltd. (002378.SZ) Income Statement Analysis – Financial Results
Hogy Medical Co.,Ltd. (HGYMF)
Industry: Medical - Instruments & Supplies
Sector: Healthcare
About Hogy Medical Co.,Ltd.
Hogy Medical Co.,Ltd., together with its subsidiaries, provides medical-use and non-woven fabric, surgical kit, and other products in Japan. It offers kit products for surgery applications; all-in-one kits for pre/mid/post-surgery; non-woven products, including gowns, personal protective equipment and wearables, drapes, packaged products, instrument table covers, and wraps; and Tigalyer, a non-woven fabric with liquid barrier properties for waterproofing applications. The company also provides sterilization products, such as hybrid Mekkin bags, hybrid Mekkin bags ID layered type, and autoclave forceps stands; Mekkin cards, which are detection cards used to judge the sterilization process when sterilizing in an autoclave; ethylene oxide gas cards that are detection cards used to judge the sterilization process when sterilizing using ethylene oxide gas; and indicator tapes for autoclave sterilization. In addition, it offers Opera Master, a surgery management system; ME equipment operation management system; narcotics/poisons box, an automatic drug reading management system using radio frequency identification; endoscope holders; and Securea, a polyurethane sponge for endoscopic surgery. The company was formerly known as Hogy Co., Ltd. and changed its name to Hogy Medical Co.,Ltd. in 1987. Hogy Medical Co.,Ltd. was incorporated in 1961 and is headquartered in Tokyo, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39.10B | 293.41M | 302.13M | 330.35M | 344.88M | 331.19M | 347.14M | 330.78M | 325.35M | 35.23B | 34.79B | 33.09B | 31.87B | 31.31B | 31.34B | 31.01B | 29.01B | 27.29B | 26.43B | 24.96B |
| Cost of Revenue | 26.04B | 179.97M | 182.09M | 199.85M | 211.83M | 206.25M | 219.69M | 191.71M | 178.19M | 17.86B | 17.05B | 16.38B | 15.71B | 14.83B | 15.14B | 15.47B | 14.09B | 13.49B | 12.86B | 12.23B |
| Gross Profit | 13.06B | 113.44M | 120.04M | 130.51M | 133.06M | 124.94M | 127.45M | 139.07M | 147.16M | 17.38B | 17.75B | 16.71B | 16.16B | 16.48B | 16.20B | 15.54B | 14.92B | 13.80B | 13.57B | 12.74B |
| Gross Profit Ratio | 33.41% | 38.66% | 39.73% | 39.51% | 38.58% | 37.72% | 36.71% | 42.04% | 45.23% | 49.32% | 51.01% | 50.50% | 50.71% | 52.64% | 51.68% | 50.10% | 51.42% | 50.57% | 51.35% | 51.02% |
| Research & Development | 0.00 | 2.85M | 3.65M | 6.13M | 5.62M | 7.13M | 4.04M | 4.35M | 3.59M | 508.00M | 620.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 7.23B | -1.06B | -998.02M | -1.00B | -985.74M | -960.79M | -907.75M | -894.08M | -880.58M | 7.00B | 7.18B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.09B | 1.12B | 1.06B | 1.08B | 1.06B | 1.04B | 986.00M | 962.00M | 946.00M | 923.00M | 894.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.32B | 60.65M | 65.98M | 73.40M | 78.26M | 78.21M | 78.25M | 67.92M | 65.42M | 7.92B | 8.08B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 8.89B | 31.00M | 132.00M | 283.00M | 324.00M | -10.00M | 4.04M | -1.09M | -275.81K | 88.00M | 134.00M | 73.00M | 51.00M | 127.00M | 134.00M | 166.00M | 73.88M | 70.62M | 32.22M | 44.86M |
| Operating Expenses | 8.89B | 63.50M | 69.63M | 79.53M | 83.89M | 85.34M | 78.25M | 73.36M | 69.28M | 8.87B | 9.00B | 8.60B | 8.41B | 7.88B | 8.22B | 8.03B | 7.68B | 7.75B | 7.37B | 7.01B |
| Cost & Expenses | 34.93B | 243.47M | 251.72M | 279.38M | 295.72M | 291.59M | 297.94M | 265.07M | 247.48M | 26.73B | 26.05B | 24.98B | 24.12B | 22.71B | 23.36B | 23.51B | 21.78B | 21.24B | 20.23B | 19.23B |
| Interest Income | 249.00M | 797.86K | 320.39K | 570.14K | 648.42K | 406.56K | 282.09K | 179.48K | 106.77K | 11.00M | 5.00M | 5.00M | 3.00M | 3.00M | 7.00M | 8.00M | 21.97M | 15.63M | 30.90M | 14.83M |
| Interest Expense | 23.00M | 218.28K | 49.29K | 18.10K | 9.26K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.00M | 20.00M | 35.00M | 50.00M | 64.24M | 23.22M | 0.00 | 0.00 |
| Depreciation & Amortization | 6.61B | 3.62B | 4.12B | 4.55B | 5.28B | 5.63B | 6.24B | 4.41B | 3.38B | 2.71B | 2.87B | 2.97B | 3.06B | 2.28B | 2.46B | 2.91B | 2.71B | 2.91B | 2.32B | 2.24B |
| EBITDA | 10.71B | 10.25B | 10.25B | 10.18B | 10.59B | 10.01B | 11.47B | 11.85B | 12.16B | 11.21B | 11.61B | 11.09B | 10.89B | 10.86B | 10.52B | 10.59B | 10.06B | 9.08B | 8.76B | 8.05B |
| EBITDA Ratio | 27.38% | 26.30% | 27.87% | 27.89% | 28.45% | 27.32% | 31.06% | 31.83% | 33.17% | 32.13% | 33.87% | 33.50% | 34.18% | 34.67% | 33.55% | 34.14% | 34.69% | 33.26% | 33.12% | 32.25% |
| Operating Income | 4.17B | 49.94M | 50.41M | 50.98M | 49.17M | 39.60M | 49.20M | 65.71M | 77.88M | 8.51B | 8.75B | 8.11B | 7.75B | 8.60B | 7.97B | 7.50B | 7.23B | 6.06B | 6.20B | 5.73B |
| Operating Income Ratio | 10.66% | 17.02% | 16.68% | 15.43% | 14.26% | 11.96% | 14.17% | 19.86% | 23.94% | 24.14% | 25.14% | 24.52% | 24.32% | 27.47% | 25.44% | 24.19% | 24.93% | 22.20% | 23.46% | 22.96% |
| Total Other Income/Expenses | -94.00M | -445.00M | 1.23M | -5.57B | 2.42B | -4.31B | 2.31B | 979.00M | -42.00M | 173.00M | 137.00M | 240.00M | 72.00M | -1.13B | 129.00M | -1.51B | -407.12M | 44.05M | 245.82M | 83.17M |
| Income Before Tax | 4.08B | 46.58M | 51.64M | 63.25M | 71.56M | 76.79M | 71.30M | 75.58M | 77.79M | 8.68B | 8.89B | 8.35B | 7.82B | 7.48B | 8.10B | 6.00B | 6.83B | 6.10B | 6.45B | 5.81B |
| Income Before Tax Ratio | 10.42% | 15.88% | 17.09% | 19.15% | 20.75% | 23.18% | 20.54% | 22.85% | 23.91% | 24.63% | 25.54% | 25.24% | 24.54% | 23.87% | 25.86% | 19.34% | 23.53% | 22.36% | 24.39% | 23.29% |
| Income Tax Expense | 1.28B | 14.33M | 16.03M | 18.64M | 20.70M | 22.19M | 21.82M | 23.66M | 25.21M | 3.02B | 3.25B | 3.11B | 3.20B | 3.02B | 3.18B | 2.41B | 2.77B | 2.48B | 2.54B | 2.32B |
| Net Income | 2.80B | 32.49M | 35.89M | 44.87M | 51.22M | 54.60M | 49.48M | 51.92M | 52.58M | 5.66B | 5.63B | 5.25B | 4.62B | 4.45B | 4.92B | 3.58B | 4.05B | 3.62B | 3.91B | 3.49B |
| Net Income Ratio | 7.17% | 11.07% | 11.88% | 13.58% | 14.85% | 16.48% | 14.25% | 15.70% | 16.16% | 16.06% | 16.19% | 15.85% | 14.51% | 14.22% | 15.70% | 11.56% | 13.98% | 13.27% | 14.79% | 14.00% |
| EPS | 115.54 | 1.34 | 1.26 | 1.48 | 1.70 | 1.79 | 1.58 | 1.66 | 1.67 | 179.91 | 179.05 | 166.81 | 147.01 | 141.55 | 157.87 | 119.24 | 134.87 | 117.35 | 123.41 | 110.11 |
| EPS Diluted | 115.54 | 1.34 | 1.26 | 1.48 | 1.70 | 1.79 | 1.58 | 1.66 | 1.67 | 179.91 | 179.05 | 166.81 | 147.01 | 141.55 | 157.87 | 119.24 | 134.87 | 117.35 | 113.71 | 100.98 |
| Weighted Avg Shares Out | 24.27M | 24.26M | 28.56M | 30.23M | 30.20M | 30.47M | 31.31M | 31.36M | 31.46M | 31.46M | 31.46M | 31.46M | 31.46M | 31.46M | 31.17M | 30.06M | 30.07M | 30.86M | 34.38M | 34.61M |
| Weighted Avg Shares Out (Dil) | 24.27M | 24.26M | 28.56M | 30.23M | 30.20M | 30.47M | 31.31M | 31.36M | 31.46M | 31.46M | 31.46M | 31.46M | 31.46M | 31.46M | 31.17M | 30.06M | 30.07M | 30.86M | 34.38M | 34.61M |
Source: https://incomestatements.info
Category: Stock Reports